Insmed | INSM - Capitaux D'Emprunt





Capitaux D'Emprunt Changement Date
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Cytokinetics USD 247.21M 868.77M 2026-03
DBV Technologies USD 0 0 2025-03
Gilead Sciences USD 20.86B 1.27B 2026-03
Heron Therapeutics USD 140.64M 975K 2025-12
Insmed USD 542.22M 1.25M 2026-03
Novartis USD 29.59B 5.35B 2025-12
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12